Gå offline med appen Player FM !
Ep. 94: “Engineering Immunity” Featuring Dr. Lili Yang
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on December 18, 2024 00:38 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 453525704 series 2895470
Guest:
Dr. Lili Yang is a Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles. Her research centers on deciphering the molecular mechanisms regulating anti-cancer immune responses, exploiting knowledge to develop novel immunotherapies for treating cancer, and translating these new cancer immunotherapies from bench to bedside. She talks about engineering off-the-shelf immunotherapies to fight cancer and generating CAR-NKT cells from hematopoietic stem and progenitor cells. She also discusses the role of serotonin and how SSRIs can affect cancer therapy efficacy.
Featured Products and Resources:
- Registration for IMMUNOLOGY2025 opens December 10!
- The 19th International Congress of Immunology to be held in Vienna from August 17-22, 2025!
The Immunology Science Round Up
Preventing Apoptosis – Apoptosis inhibition by NLRP3 activators is due to their effects on mitochondria rather than inflammasome activation.
SARS-CoV-2 Spike Proteins in the Brain – SARS-CoV-2 spike protein persists in the skull-meninges-brain axis in COVID-19 patients.
CAR T to Protect Transplanted Beta Cells – hPSCs and Tregs can be co-engineered to protect hPSC-derived cells from immune rejection upon transplantation.
Endogenous Retrovirus Antibodies – An antibody produced by endogenous retrovirus-reactive B cells recognized glycans of a broad range of enveloped viruses.
Image courtesy of Dr. Lili Yang
115 episoder
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on December 18, 2024 00:38 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 453525704 series 2895470
Guest:
Dr. Lili Yang is a Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles. Her research centers on deciphering the molecular mechanisms regulating anti-cancer immune responses, exploiting knowledge to develop novel immunotherapies for treating cancer, and translating these new cancer immunotherapies from bench to bedside. She talks about engineering off-the-shelf immunotherapies to fight cancer and generating CAR-NKT cells from hematopoietic stem and progenitor cells. She also discusses the role of serotonin and how SSRIs can affect cancer therapy efficacy.
Featured Products and Resources:
- Registration for IMMUNOLOGY2025 opens December 10!
- The 19th International Congress of Immunology to be held in Vienna from August 17-22, 2025!
The Immunology Science Round Up
Preventing Apoptosis – Apoptosis inhibition by NLRP3 activators is due to their effects on mitochondria rather than inflammasome activation.
SARS-CoV-2 Spike Proteins in the Brain – SARS-CoV-2 spike protein persists in the skull-meninges-brain axis in COVID-19 patients.
CAR T to Protect Transplanted Beta Cells – hPSCs and Tregs can be co-engineered to protect hPSC-derived cells from immune rejection upon transplantation.
Endogenous Retrovirus Antibodies – An antibody produced by endogenous retrovirus-reactive B cells recognized glycans of a broad range of enveloped viruses.
Image courtesy of Dr. Lili Yang
115 episoder
Todos los episodios
×Velkommen til Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.